Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial

Zuranolone provides a rapid response without chronic dosing: Response to correspondence by ten Doesschate et al.

(2022) Alix Arnaud et al.   JOURNAL OF AFFECTIVE DISORDERS

Allopregnanolone in mood disorders: mechanism and therapeutic development

(2021) Shiyi Chen et al.   PHARMACOLOGICAL RESEARCH

Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala

(2021) Pantelis Antonoudiou et al.   BIOLOGICAL PSYCHIATRY

Non-superiority of zuranolone (SAGE-217) at the longer-term

(2021) F. ten Doesschate et al.   JOURNAL OF AFFECTIVE DISORDERS

Treatment-Resistant Depression: Approaches to Treatment

(2021) Karan S. Kverno et al.   JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES

Pharmacological management of depression: Japanese expert consensus

(2020) Hitoshi Sakurai et al.   JOURNAL OF AFFECTIVE DISORDERS

The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins

(2020) Felipe Borges Almeida et al.   Neurobiology of Stress

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

(2020) Dawn F Ionescu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Trial of SAGE-217 in Patients with Major Depressive Disorder

(2019) Handan Gunduz-Bruce et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder

(2018) M. Bixo et al.   JOURNAL OF NEUROENDOCRINOLOGY

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Improving Depression Outcome by Patient-Centered Medical Management

(2018) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor

(2017) Gabriel Martinez Botella et al.   JOURNAL OF MEDICINAL CHEMISTRY

Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence

(2013) Elisabetta Poluzzi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prescription patterns following first-line new generation antidepressants for depression in Japan: A naturalistic cohort study based on a large claims database

(2013) Toshi A. Furukawa et al.   JOURNAL OF AFFECTIVE DISORDERS